Study record · Thymalin
Peptides of pineal gland and thymus prolong human life
The report describes lower morbidity and mortality in peptide-treated groups.
Key result
The report describes lower morbidity and mortality in peptide-treated groups.
Study details
Study designLong-term regional clinical report; randomization/blinding not clear from accessible abstract
PopulationOlder adults
Sample size266
RouteRegimen not fully verifiable from abstract
Regimen / exposureThymalin and/or Epithalamin courses during early years of follow-up
Duration6–8 years follow-up
ComparatorControl group
Primary endpoint / questionMorbidity and mortality in older adults
Safety resultModern adverse-event ascertainment is not clearly described in the abstract.
Key limitationsOlder regional evidence, incomplete methods in accessible abstract, unusually large claimed effects and limited independent replication; low certainty.
Registry / identifierPMID 14523363